Jim Datin

Jim Datin

Director/Board Member at ORASURE TECHNOLOGIES, INC.

Net worth: 432 088 $ as of 2024-04-29

61 year
Health Technology
Finance
Technology Services

Profile

Mr. Jim A.
Datin
is an Operating Partner at GHO Capital Partners LLP, an Independent Director at OraSure Technologies, Inc., a Chief Executive Officer & Director at BALX Holdings LLC and a Co-Managing Director at BioAgilytix Europe GmbH.
He is on the Board of Directors at OraSure Technologies, Inc., The North Carolina Biotechnology Center, BALX Holdings LLC, Celerant Consulting, Inc., Hepatitis B Foundation and Life Sciences Pennsylvania.
Mr. Datin was previously employed as an Independent Director by FSD Pharma, Inc., a Non-Executive Director by BioAgilytix Labs LLC, an Independent Director by NuPathe, Inc., a Vice Chairman by University City Science Center, an Executive Vice President & Managing Director by Safeguard International Management LLC, an EVP & Managing Director-Life Sciences Group by Safeguard Scientifics, Inc., a Chairman by Clarient, Inc., a Chief Executive Officer by TouchPoint Solutions, a Group President by Dendrite International, Inc., a Group Director-Corporate Business Strategy by GlaxoSmithKline, Inc., a Chief Executive Officer by Golden Land Bhd., a Director-International Business by Baxter Corp., a Member by Ben Franklin Technology Partners /Ventures/, a Chairman by Laureate Biopharmaceutical Services, Inc., a Director-International Business by Merck KGaA, and a Group Director by Smithkline Beckman Corp.
He also served on the board at Acelerate, Inc., Intralinks Holdings, Inc., NovaSom, Inc., Putney, Inc., Rubicor Medical, Inc., Sotera Wireless, Inc. and Ventaira Pharmaceuticals, Inc. He received his undergraduate degree from Marshall University, an undergraduate degree from The Wharton School of the University of Pennsylvania and an MBA from the University of New Haven.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-13 82,146 ( 0.11% ) 432 088 $ 2024-04-29

Jim Datin active positions

CompaniesPositionStart
ORASURE TECHNOLOGIES, INC. Director/Board Member 2019-08-10
Hepatitis B Foundation Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member 2016-12-31
Chief Executive Officer -
Chief Executive Officer -
Private Equity Investor 2023-02-28
All active positions of Jim Datin

Former positions of Jim Datin

CompaniesPositionEnd
Chief Executive Officer 2022-06-15
░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Jim Datin's experience

Training of Jim Datin

Marshall University Undergraduate Degree
University of New Haven Masters Business Admin
The Wharton School of the University of Pennsylvania Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jim Datin's experience

Connections

100 +

1st degree connections

34

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
SAFEGUARD SCIENTIFICS, INC.

Finance

MERCK KGAA

Health Technology

ORASURE TECHNOLOGIES, INC.

Health Technology

GOLDEN LAND

Finance

FSD PHARMA INC.

Health Technology

Private companies26

Technology Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Technology Services

Health Technology

Health Technology

Health Technology

Technology Services

Miscellaneous

Technology Services

Finance

Finance

Commercial Services

Health Technology

Commercial Services

Hepatitis B Foundation

Commercial Services

Health Technology

Commercial Services

Finance

See company connections